FP-016:Neurology; Psychiatry

FP-016 is a ready-to-use, subcutaneous, long-acting injectable dosage form targeting sustained and stable plasma and CNS concentrations of active drug for the treatment of neurological diseases.

Monthly, subcutaneous injections reduce the frequency of administration to patients and can also help address the need of patients that have difficulties with oral dosing, thereby improving patient compliance.

This program, which has the potential of transforming the treatment landscape in its therapeutic category, is at IND-enabling stage.